COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,799 Articles (22,527 medRxiv, 8,272 bioRxiv)

Most recent first Previous |  Page 2108: Articles 21071-21080  | Next

Intrinsic Signal Amplification by Type-III CRISPR-Cas Systems Provides a Sequence-Specific Viral Diagnostic
Santiago-Frangos, A., Nemudryi, A. A., Nemudraia, A., Hall, L. N., Krishna, P., Wiegand, T., Wilkinson, R. A., Snyder, D. T., Hedges, J. F., Jutila, M. A., Taylor, M. P., Wiedenheft, B.
10.1101/2020.10.14.20212670 — Posted: 2020-10-20
Characteristics of COVID-19 Clinical Trials in India Based on the Registration Data on CTRI (Clinical Trials Registry- India): a cross-sectional analysis
Parameswaran, S., MS, S. D., K, K., NP, V.
10.1101/2020.10.14.20212761 — Posted: 2020-10-20
A Multiplexed, Next Generation Sequencing Platform for High-Throughput Detection of SARS-CoV-2
Aynaud, M.-M., Hernandez, J. J., Barutcu, S., Braunschweig, U., Chan, K., Pearson, J. D., Trcka, D., Prosser, S. L., Kim, J., Barrios-Rodiles, M., Jen, M., Song, S., Shen, J., Bruce, C., Hazlett, B., Poutanen, S., Attisano, L., Bremner, R., Blencowe, B., Mazzulli, T., Han, H., Pelletier, L., Wrana, J. L.
10.1101/2020.10.15.20212712 — Posted: 2020-10-20
Integration of Kalman filter in the epidemiological model: a robust approach to predict COVID-19 outbreak in Bangladesh
Islam, M. S., Hoque, M. E., Amin, M. R.
10.1101/2020.10.14.20212878 — Posted: 2020-10-20
Characteristics and evolution of COVID-19 cases in Brazil: mathematical modeling and simulation
Passos, C. A. C., Vieira, E. A., Lourenco, J. A., do Nacimento, J. O.
10.1101/2020.10.14.20212829 — Posted: 2020-10-20
Prediction of Covid-19 Infections Through December 2020 for 10 US States Incorporating Outdoor Temperature and School Re-Opening Effects-September Update
Newell, T. A.
10.1101/2020.10.15.20213223 — Posted: 2020-10-20
Antibody Immunological Imprinting on COVID-19 Patients
Aydillo, T., Rombauts, A., Stadlbauer, D., Aslam, S., Abelenda-Alonso, G., Escalera, A., Amanat, F., Jiang, K., Krammer, F., Carratala, J., Garcia-Sastre, A.
10.1101/2020.10.14.20212662 — Posted: 2020-10-20
A Sensitive, Rapid, and Portable CasRx-based Diagnostic Assay for SARS-CoV2
Brogan, D. J., Chaverra-Rodriguez, D., Lin, C. P., Smidler, A. L., Yang, T., Alcantara, L. M., Antoshechkin, I., Liu, J., Raban, R. R., Belda-ferre, P., Knight, R., Komives, E. A., Akbari, O. S.
10.1101/2020.10.14.20212795 — Posted: 2020-10-20
2.5 Million Person-Years of Life Have Been Lost Due to COVID-19 in the United States
ELLEDGE, S. J.
10.1101/2020.10.18.20214783 — Posted: 2020-10-20 Discussion: Onsite
SARS-CoV-2 genome-wide mapping of CD8 T cell recognition reveals strong immunodominance and substantial CD8 T cell activation in COVID-19 patients
Saini, S. K., Hersby, D. S., Tamhane, T., Povlsen, H. R., Amaya Hernandez, S. P., Nielsen, M., Gang, A. O., Hadrup, S. R.
10.1101/2020.10.19.344911 — Posted: 2020-10-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).